Osaic Holdings
HQL

Osaic Holdings’s abrdn Life Sciences Investors HQL Stock Holding History

Osaic Holdings’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$597K Sell
36,692
-1,289
-3% -$21.5K ﹤0.01% 3178
2025
Q4 		$637K Buy
37,981
+4,966
+15% +$83.4K ﹤0.01% 3119
2025
Q3 		$480K Buy
33,015
+2,556
+8% +$35K ﹤0.01% 3457
2025
Q2 		$390K Buy
30,459
+6,802
+29% +$83.9K ﹤0.01% 3362
2025
Q1 		$300K Buy
23,657
+8,959
+61% +$121K ﹤0.01% 3295
2024
Q4 		$193K Sell
14,698
-68
-0.5% -$981 ﹤0.01% 3632
2024
Q3 		$223K Buy
14,766
+274
+2% +$4.15K ﹤0.01% 3563
2024
Q2 		$205K Sell
14,492
-61,151
-81% -$827K ﹤0.01% 3535
2024
Q1 		$1.03M Buy
75,643
+2,612
+4% +$36.1K ﹤0.01% 2299
2023
Q4 		$983K Sell
73,031
-11,452
-14% -$141K ﹤0.01% 2522
2023
Q3 		$1.05M Buy
84,483
+8,443
+11% +$111K ﹤0.01% 2592
2023
Q2 		$1.03M Buy
76,040
+1,271
+2% +$17.5K ﹤0.01% 2495
2023
Q1 		$1.04M Buy
74,769
+3,986
+6% +$57K ﹤0.01% 2424
2022
Q4 		$1.01M Buy
70,783
+3,735
+6% +$54.1K ﹤0.01% 2357
2022
Q3 		$917K Buy
67,048
+267
+0.4% +$3.99K ﹤0.01% 2317
2022
Q2 		$951K Sell
66,781
-2,164
-3% -$32.7K ﹤0.01% 2320
2022
Q1 		$1.14M Sell
68,945
-15,094
-18% -$260K ﹤0.01% 2448
2021
Q4 		$1.62M Sell
84,039
-50,856
-38% -$1.02M ﹤0.01% 1962
2021
Q3 		$2.8M Buy
134,895
+1,409
+1% +$30.2K 0.01% 1450
2021
Q2 		$2.86M Sell
133,486
-3,288
-2% -$66.4K 0.01% 1432
2021
Q1 		$2.69M Buy
136,774
+2,478
+2% +$51.1K 0.01% 1373
2020
Q4 		$2.65M Buy
134,296
+503
+0.4% +$9.3K 0.01% 1237
2020
Q3 		$2.35M Buy
133,793
+9,285
+7% +$166K 0.01% 1207
2020
Q2 		$2.23M Buy
124,508
+10,956
+10% +$188K 0.01% 1196
2020
Q1 		$1.7M Buy
+113,552
New +$1.86M 0.01% 1165

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Osaic Holdings's HQL Position: Q1 2026 in Review

Osaic Holdings reduced its abrdn Life Sciences Investors (HQL) stake by 3.4% in Q1 2026, selling an estimated $21.5K and leaving 36,692 shares worth $597K. The position accounts for ﹤0.01% of the portfolio, ranked #3178.

Osaic Holdings first reported a position in HQL in Q1 2020 and has held it in 25 quarters since. The position peaked at $2.86M in Q2 2021. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

  • Osaic Holdings held 36,692 shares of abrdn Life Sciences Investors worth $597K as of Q1 2026.
  • Osaic Holdings sold 1,289 abrdn Life Sciences Investors shares in Q1 2026, an estimated $21.5K.
  • abrdn Life Sciences Investors made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #3178 holding.
  • Osaic Holdings first reported a position in abrdn Life Sciences Investors in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's abrdn Life Sciences Investors position peaked at $2.86M in Q2 2021.
  • 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.